Clinical Trials Sponsored by The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Fou...

Total 27 results

The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Not yet recruiting

Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients

Leprosy

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Completed

Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella (BIOMR)

Measles | Rubella

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Foundation

Recruiting

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Guillain-Barre Syndrome | Transverse Myelitis | Acute Disseminated Encephalomyelitis | Vaccine-induced Thrombotic Thrombocytopenia Syndrome

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed

Measles

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Unknown

Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa

Renal Insufficiency, Chronic | Red-Cell Aplasia, Pure
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Meningitis, Meningococcal, Serogroup C

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Active, not recruiting

Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.

COVID-19

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military

Yellow Fever Vaccine

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers

Chronic Viral Hepatitis C

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

Measles | Rubella | Mumps

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Not yet recruiting

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Measles Vaccine
The Immunobiological Technology Institute (Bio-Manguinhos)...

Recruiting

Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine

COVID-19

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Active, not recruiting

Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control Study

COVID-19 Vaccines

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Active, not recruiting

Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.

Foot Ulcer, Diabetic | Epidermal Growth Factor
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) Screening

Mass Screening

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Unknown

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Serogroup C Meningococcal Meningitis

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations (MMR)

Measles | Rubella | Mumps

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Immunity After Two Doses of Yellow Fever Vaccine (IATDYFV)

Yellow Fever

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
GlaxoSmithKline

Completed

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Measles | Rubella | Mumps | Varicella

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Wellcome Trust

Unknown

Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary Study

Yellow Fever Vaccine

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Rockefeller University

Recruiting

Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers

Drug-Related Side Effects and Adverse Reactions

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Ministry of Health, Brazil

Active, not recruiting

Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)

Immunity | Yellow Fever Vaccine

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella (MR)

Measles | Rubella

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Hospital de Clinicas de Porto Alegre

Unknown

BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C (BIP48II/III)

Chronic Hepatitis C

Brazil
The Immunobiological Technology Institute (Bio-Manguinhos)...
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Unknown

Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children

Human Immunodeficiency Virus | Human Immunodeficiency Virus Transmission | Diagnoses, Syndromes, and Conditions

Brazil
Maria de Lourdes de Sousa Maia, MD

Not yet recruiting

Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil.

Pneumococcal Vaccines
The Immunobiological Technology Institute (Bio-Manguinhos)...
Hospital Universitário Clementino Fraga Filho; Hospital Federal de Bonsucesso...

Completed

Interferon α 2b Pharmacovigilance Study

Hepatitis C, Chronic

Brazil

Clinical Trials Sponsored by The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Fou...

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations